This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 1998-2003.
Company Filing History:
Years Active: 1998-2003
Title: Innovations and Contributions of Christopher Logothetis
Introduction
Christopher Logothetis is a notable inventor based in Houston, TX (US). He has made significant contributions to the fields of hyperproliferative diseases and angiogenesis. With a total of 2 patents, his work has implications for cancer research and treatment.
Latest Patents
Logothetis' latest patents include "C-CAM as an angiogenesis inhibitor" and "Bone and prostate-derived protein factors affecting prostate cancer." The first patent discusses the role of the C-CAM1 cytoplasmic domain in inhibiting angiogenesis, which is crucial for controlling hyperproliferative cell growth. The second patent identifies a human growth factor polypeptide that plays a role in prostate cancer, highlighting the importance of PSA stimulating autocrine factors in androgen-independent prostate cell growth.
Career Highlights
Logothetis is affiliated with the University of Texas System, where he continues to advance research in his field. His work has garnered attention for its potential to impact cancer therapies and improve patient outcomes.
Collaborations
He has collaborated with notable colleagues such as Sue-Hwa Lin and Weiping Luo, contributing to a rich environment of innovation and research.
Conclusion
Christopher Logothetis exemplifies the spirit of innovation in medical research, particularly in the fight against cancer. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving health outcomes.